Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 2/20 | 0.61 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.54 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.54 |
| ▸ | OPRM1 | P35372 | 17/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.44 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6164718 | 0.82 | HTT (0.41) | HTTHDAC1HDAC6OPRM1KMT2A | |
| SCHEMBL6164113 | 0.82 | OPRM1 (0.49) | HTTHDAC1HDAC6OPRM1KMT2A | |
| SCHEMBL6164100 | 0.82 | HDAC1 (0.45) | HTTHDAC1HDAC6OPRM1KMT2A | |
| SCHEMBL6162828 | 0.81 | ALPL (0.63) | HTTHDAC1HDAC6OPRM1KMT2A | |
| SCHEMBL6166123 | 0.80 | ALPL (0.43) | HTTHDAC1HDAC6OPRM1KMT2A | |
| SCHEMBL6166168 | 0.78 | OPRM1 (0.55) | HTTHDAC1HDAC6OPRM1KMT2A | |
| SCHEMBL6165167 | 0.76 | HTT (1.00) | HTTHDAC1HDAC6OPRM1 | |
| SCHEMBL6163085 | 0.75 | HDAC1 (0.68) | HTTHDAC1HDAC6OPRM1KMT2A | |
| SCHEMBL6165665 | 0.74 | ALPL (0.39) | HTTHDAC1HDAC6OPRM1KMT2A | |
| SCHEMBL6166699 | 0.73 | HTT (0.61) | HTTHDAC1HDAC6OPRM1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1177185-B1 | 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS | PHARMACIA ITALIA SPA (IT) | 2005-04-20 | — | — | EP | disclosed |
| US-6716856-B1 | CELL PROLIFERATIVE DISORDERS OR ALZHEIMER'S DISEASE; REDUCED TOXICITY; CDK/CYCLIN KINASE INHIBITORY ACTIVITY | PHARMACIA & TUBJOHN SPA (IT) | 2004-04-06 | — | — | US | disclosed |